was added to 2 ml of scintillation solution (Cyto-Scint, MP, Irvine, CA), and radioactivity counted. Measurement of mRNA expression Total RNA was extracted using the RNAqueous kit, according the manufacture’s instruction. DNA-free kit was also applied to remove contaminating DNA from RNA preparation. Total RNA was treated with superscript II reverse transcriptase. Real-time RT-PCR was performed with 25 ml of master mix containing 26Syber Green buffer mix and forward and reverse primers (Invitrogen). The internal control was the constitutively expressed housekeeping human cyclophilin A. Primers for human ATX were as follows: sense, 59-ACAACGAGGAGAGCTG CAAT-39; antisense, 59-AGAAGTCCAGGCTGGTGAGA-39 ; for human cyclophilin A: sense, 59-TTCATCTGCACTGCCAAGAC-39; antisense, 59-TCGAGTTGTCCACAGT CACC-39; for hu- man LPA1: sense, 59-ACAGCCATGAAT GAAC CA CA-39; antisense, 59-TCTCCGAGTATTGGGTCCTG-39; for human LPA2: sense, 59-GTGCAGGAATCTGGCTCTTC-39; antisense, References 1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106–130. 2. Bergstralh DT, Ting JP (2006) Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. Cancer Treat Rev 32: 166–179. 3. Snyder JP, Nettles JH, Cornett B, Downing KH, Nogales E (2001) The binding conformation of Taxol in beta-tubulin: a model based on electron crystallo- graphic density. Proc Natl Acad Sci U S A 98: 5312–5316. 4. McGrogan BT, Gilmartin B, Carney DN, McCann A (2008) Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta 1785: 96–132. 5. Krajewski S, Krajewska M, Turner BC, Pratt C, Howard B, et al. (1999) Prognostic significance of apoptosis regulators in breast cancer. Endocr Relat Cancer 6: 29–40. 6. Samadi N, Bekele R, Capatos D, Venkatraman G, Sariahmetoglu M, et al. (2010) Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance. Biochimie. 7. Samadi N, Gaetano C, Goping IS, Brindley DN (2009) Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis. Oncogene 28: 1028–1039. 8. Go´mez-Mun˜ oz A, Waggoner DW, O’Brien L, Brindley DN (1995) Interaction of ceramides, sphingosine, and sphingosine 1-phosphate in regulating DNA synthesis and phospholipase D activity. J Biol Chem 270: 26318–26325. 9. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139–150. 10. Kolesnick R, Fuks Z (2003) Radiation and ceramide-induced apoptosis. Oncogene 22: 5897–5906. 11. Charles AG, Han TY, Liu YY, Hansen N, Giuliano AE, et al. (2001) Taxol- induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother Pharmacol 47: 444–450. 12. Martinez R, Navarro R, Lacort M, Ruiz-Sanz JI, Ruiz-Larrea MB (2009) Doxorubicin induces ceramide and diacylglycerol accumulation in rat hepatocytes through independent routes. Toxicol Lett 190: 86–90. 13. Ji C, Yang B, Yang YL, He SH, Miao DS, et al. (2010) Exogenous cell- permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin- induced apoptosis by promoting AMPK activation and mTORC1 inhibition. Oncogene. 14. Murakami M, Shiraishi A, Tabata K, Fujita N (2008) Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysopho- sphatidic acid receptor. Biochem Biophys Res Commun 371: 707–712. 15. Pasternack SM, von Kugelgen I, Aboud KA, Lee YA, Ruschendorf F, et al. (2008) G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat Genet 40: 329–334. 16. Nakanaga K, Hama K, Aoki J (2010) Autotaxin–an LPA producing enzyme with diverse functions. J Biochem 148: 13–24. 17. Moolenaar WH, van Meeteren LA, Giepmans BN (2004) The ins and outs of lysophosphatidic acid signaling. Bioessays 26: 870–881. 18. Federico L, Pamuklar Z, Smyth SS, Morris AJ (2008) Therapeutic potential of autotaxin/lysophospholipase d inhibitors. Curr Drug Targets 9: 698–708. 19. Albers HM, Dong A, van Meeteren LA, Egan DA, Sunkara M, et al. (2010) Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation. Proc Natl Acad Sci U S A 107: 7257–7262. Lysophosphatidate Reverses G2/M Arrest by Taxol 59-GGGTGTCCACAGTCTGTCCT-39; for human LPA3 recep- tor: sense, 59-TGCTCATTTTGCTTGTCTGG-39 and antisense, ATGATGAGGAAGGCCATGAG. Samples were assayed in triplicate on the 7500 Real Time PCR System (Applied Biosystems). Statistical Analysis Statistical analysis was performed by analysis of variance with a Kruskal-Wallis post hoc test. Acknowledgments We thank Mr. J. Dewald for excellent technical assistance and Drs F. Bamforth and G. S. Cembrowski for their support. Author Contributions Conceived and designed the experiments: DNB NS ISG LSM. Performed the experiments: NS RTB. Analyzed the data: NS LMS DNB. Contributed reagents/materials/analysis tools: ISG LSM DNB. Wrote the paper: DNB NS LSM ISG. 20. Tomsig JL, Snyder AH, Berdyshev EV, Skobeleva A, Mataya C, et al. (2009) Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo. Biochem J 419: 611–618. 21. Jasinska R, Zhang QX, Pilquil C, Singh I, Xu J, et al. (1999) Lipid phosphate phosphohydrolase-1 degrades exogenous glycerolipid and sphingolipid phos- phate esters. Biochem J 340 (Pt 3): 677–686. 22. Yang SY, Lee J, Park CG, Kim S, Hong S, et al. (2002) Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin Exp Metastasis 19: 603–608. 23. Nam SW, Clair T, Campo CK, Lee HY, Liotta LA, et al. (2000) Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 19: 241–247. 24. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, et al. (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158: 227–233. 25. Liu S, Go´mez-Mun˜ oz M, Murph M, Lu Y, Liu W, et al. (2009) Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigen- esis, invasion, and metastases. Cancer Cell 15: 539–550. 26. Gaetano CG, Samadi N, Tomsig JL, Macdonald TL, Lynch KR, et al. (2009) Inhibition of autotaxin production or activity blocks lysophosphatidylcholine- induced migration of human breast cancer and melanoma cells. Mol Carcinog 48: 801–809. 27. Saunders LP, Ouellette A, Bandle R, Chang WC, Zhou H, et al. (2008) Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion. Mol Cancer Ther 7: 3352–3362. 28. Vidot S, Witham J, Agarwal R, Greenhough S, Bamrah HS, et al. (2010) Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells. Cell Signal 22: 926–935. 29. Marchetti P, Urien S, Cappellini GA, Ronzino G, Ficorella C (2002) Weekly administration of paclitaxel: theoretical and clinical basis. Crit Rev Oncol Hematol 44 Suppl: S3–13. 30. Cheng H, Wu Y, An S, Dong S, Chen H, et al. (2009) In vitro sequence- dependent interaction between paclitaxel and gefitinib in human lung cancer cell lines. J Clin Oncol 27: suppl; abstr e22025. 31. Liang Y, Yan C, Schor NF (2001) Apoptosis in the absence of caspase 3. Oncogene 20: 6570–6578. 32. Singh R, Pervin S, Wu G, Chaudhuri G (2001) Activation of caspase-3 activity and apoptosis in MDA-MB-468 cells by N(omega)-hydroxy-L-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines. Carcinogenesis 22: 1863–1869. 33. Hembruff SL, Laberge ML, Villeneuve DJ, Guo B, Veitch Z, et al. (2008) Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance. BMC Cancer 8: 318. 34. Guo B, Villeneuve DJ, Hembruff SL, Kirwan AF, Blais DE, et al. (2004) Cross- resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure. Breast Cancer Res Treat 85: 31–51. 35. Mickley L, Jain P, Miyake K, Schriml LM, Rao K, et al. (2001) An ATP-binding cassette gene (ABCG3) closely related to the multidrug transporter ABCG2 (MXR/ABCP) has an unusual ATP-binding domain. Mamm Genome 12: 86–88. 36. Takabe K, Kim RH, Allegood JC, Mitra P, Ramachandran S, et al. (2010) Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem 285: 10477–10486. PLoS ONE | www.plosone.org 11 May 2011 | Volume 6 | Issue 5 | e20608